Skip to main content

Month: May 2021

Berkeley Lights Reports First Quarter 2021 Financial Results

Q1 2021 revenue increased 35% year over year EMERYVILLE, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended March 31, 2021. Recent HighlightsTotal revenue of $18.6 million for the first quarter of 2021, representing 35% growth year over yearGrew the installed base to 85 platforms during the first quarter of 2021, with eight new direct placements and two existing platforms added upon the successful completion of a joint development and partnership programAnnounced the launch of Opto Assure, the first of a series of assays that will provide yield and product quality data at an earlier stage in cell developmentAppointed Greg Lucier as Chairperson and John Chiminski as an Independent Director to its Board of...

Continue reading

Fit Soda™ Now Carried in Over 1,100 Food Lion Supermarkets in the Mid-Atlantic and Southeastern Regions of the United States

Food LionAs of Monday, May 10, 2021, Fit Soda™ is now available in all 1,100+ stores of supermarket chain Food Lion, located in the Mid-Atlantic and Southeastern areas of the United States. This placement complements the existing presence of Fit Soda™ throughout the country, including in famous regional chains such as HEB and Sprouts.After announcing placements of Fit Soda™ in well-known regional grocery chains such as HEB and Sprouts, Koios is pleased to announce that its Fit Soda™ functional beverage is now available in all Food Lion supermarkets, a chain which operates more than 1,100 grocery stores in the eastern United States. As the sugar-free beverage category continues to grow, Coca-Cola recently announced its prediction that its “Coke Zero Sugar” variety will be the firm’s biggest driver of growth in 2021 and...

Continue reading

Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID

100% overall survival and ≥95% event-free survival observed at two and three years following one-time treatment with lentiviral HSC gene therapy 50 total participants represent largest published dataset of gene therapy-treated patients with a monogenic condition to date BOSTON and LONDON, May 11, 2021 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced data published in the New England Journal of Medicine (NEJM) evaluating the safety and efficacy of investigational gene therapy products, including OTL-101, for the treatment of adenosine deaminase severe combined immunodeficiency (ADA-SCID). Fifty (50) ADA-SCID patients were treated with investigational gene therapy composed of autologous CD34+ hematopoietic stem cells (HSCs) transduced ex vivo with a self-inactivating lentiviral...

Continue reading

Loop Insights Signs LOI To Become Official Technology Partner To $2.7 Billion All Net Resort and Arena Project In Las Vegas

Revolutionary Non-Gaming Business & Family Friendly Las Vegas Destination Includes Multi-Purpose Arena With Retractable Roof and Two Hotel Towers VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — Loop Insights Inc. (TSX.V: MTRX) (RACMF:OTCQB) (the “Company” or “Loop”), a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement, is pleased to announce the signing of a Letter of Intent (LOI) with All Net LLC (“All Net”) to provide a custom technology stack that will power the All Net Resort and Arena Project (“All Net Resort”), a new $USD 2.7 Billion entertainment venue in Las Vegas, Nevada. At the core of the partnership will be Loop’s real-time AI data intelligence and digital wallet platform. REVOLUTIONARY...

Continue reading

Rubicon Organics to Report Q1 2021 Results

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce that it will be reporting its financial results for the first quarter ended March 31, 2021 (“Q1 2021”) before market open on Tuesday, May 18, 2021. The Company will be hosting a conference call to discuss Q1 2021 results on May 18, 2021. Conference call details are as follows:Date and time: 7:00 AM PT / 10:00 AM ETConference ID: 2699002Local dial-in: (833) 900-2238International dial-in: (647) 689-5136Webcast: https://onlinexperiences.com/Launch/QReg/ShowUUID=C4504707-166F-4539-B5A1-E58E4DEF03BEABOUT RUBICON ORGANICS INC. Rubicon Organics Inc. is becoming...

Continue reading

InspireMD Announces First Quarter 2021 Financial Results

Company Completes Up-List to Nasdaq Capital Market, with Trading Becoming Effective May 21, 2021 Management to host investor conference call today, May 11, 2021, at 8:30am ET TEL AVIV, Israel, May 11, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the first quarter ended March 31, 2021. First Quarter 2021 and recent highlights:Announced the up-list to the Nasdaq Capital Market, on which the company’s stock will be traded beginning May 21, 2021 Announced reverse stock split of 1:15 with subsequent successful up-listing of shares on the Nasdaq Capital Market. Announced the closing of an upsized underwritten public offering...

Continue reading

SecureLink Acquires Leading Data Governance Company Maize Analytics

Maize Analytics’ machine learning capabilities strengthens SecureLink’s ecosystem of third-party remote access and security solutions AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE) — Today, SecureLink, a leader in third-party remote access and security, has acquired Maize Analytics, a leading provider of data governance solutions, to tackle organizations’ largest security risks and bring compliance innovation to the market. “By combining SecureLink’s unique third-party security features with Maize Analytics’ innovative machine learning capabilities to secure insider access, we are extending our solutions for our customers – one that covers both employee and third-party access to the most mission critical and sensitive systems,” said Joe Devine, CEO of SecureLink. Maize Analytics technology identifies non-compliant or...

Continue reading

Enzymes Market Size 2021 | Is Projected to Reach USD 13,815.2 Million by 2027, Exhibiting a CAGR of 6.4%

Top Players Covered in the Enzymes Market Research Report are BASF SE (Ludwigshafen, Germany), DuPont (Delaware, U.S), DSM (Heerlen, Netherlands), Novozyme (Bagsværd, Denmark), Roche Holding (Basel, Switzerland), Codeix (California, U.S.), Sanofi (Paris, France), Advanced Enzymes (Maharashtra, India), and other key market players Pune, India, May 11, 2021 (GLOBE NEWSWIRE) — The global enzymes market size is projected to reach USD 13,815.2 million by 2027, exhibiting a CAGR of 6.4% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Enzymes Market, 2020-2027”. As per the report, the value of the market stood at USD 9,008.7 million in 2019. The increasing demand for polymerases- and nucleases-based pharmaceuticals are stoking the demand in the healthcare industry. Industry leaders...

Continue reading

Telemedicine Market Size 2021 | Is Projected Reach USD 396.76 Billion by 2026 Exhibiting CAGR of 25.8%: Fortune Business Insights

Telemedicine Market Key Players Studied In this Report are American Well (Boston, U.S.), MDLIVE Inc. (Sunrise, U.S), Teladoc Health Inc. (Purchase, U.S.), Doctor on Demand Inc. (San Francisco, U.S.), MeMD (Arizona, U.S.), Encounter Telehealth (Nebraska, U.S.), Global Med (Arizona, U.S.), SnapMD (California, U.S.), Other prominent players. Pune, India, May 11, 2021 (GLOBE NEWSWIRE) — According to the report by Fortune Business Insights, Telemedicine market size is projected reach USD 396.76 Billion by 2026. Global Telemedicine market was USD 41.63 billion in 2018 and is anticipated to exhibit a CAGR of 25.8% during the forecast period set between 2019 to 2026. The increasing adoption and accessibility of digital health technologies will accelerate the telemedicine market growth in the forthcoming years Government Funding for Telemedicine...

Continue reading

Berkeley Lights Announces Changes to Board of Directors

Gregory T. Lucier named Board Chairperson, succeeding Michael Marks John Chiminski joins Board as an Independent Director EMERYVILLE, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Gregory T. Lucier has been named Chairperson of the Board of Directors, effective May 14, 2021. He will succeed Michael Marks, who is retiring from the Board. Concurrent with this appointment, John Chiminski, chief executive officer and chairperson of Catalent, will join the Berkeley Lights’ Board as an independent director. “I am honored to be appointed Board Chair and continue to work alongside the Berkeley Lights team to enable a future where cells are a scalable and sustainable way to manufacture the products that we need to live a long and healthy life,” said...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.